John has over 15 years of clinical research industry experience in peri- and post-approval research (Phase II – IV) and has worked in the pharmaceutical industry for over 25 years. He has extensive experience working in peri- and post-approval research and has overseen many different types of studies, including observational, PASS, marketing studies, expanded access, and Phase IIIb / Phase IV studies in most therapeutic areas, and is now responsible for Respiratory and Infectious Diseases.
Prior to his current role, John started his career in clinical trial supplies for Beecham Pharmaceuticals. He then moved to Wyeth Laboratories and worked in several departments from quality control to process development, as well as over-the-counter new product development for Whitehall New Product Development Centre (part of the Wyeth group). John then worked at Link Pharmaceuticals initially as their technical manager, subsequently becoming the development manager where he was responsible for product development. At that point, he became interested in clinical research while outsourcing clinical studies to CROs and moved to Kendle CRO.
John has an MSc in Pharmaceutical Sciences from the University of Manchester.